Indrin Chetty named vice chair of research, director of medical physics division in Department of Radiation Oncology at Cedars-Sinai

UT Southwestern brings radiation oncology to $177M campus in Fort Worth Medical District

To meet the growing demands for cancer treatment in Tarrant County and surrounding areas, UT Southwestern Medical Center is expanding its cancer services in the Fort Worth Medical District with construction of a two-story radiation oncology campus that will house the city’s first MRI-guided precision radiation treatment.

December 06, 2024

Vol.50 No.45

Clinical Roundup

ASTRO survey finds prior authorization delays lead to serious harm for people with cancer

A new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms people with cancer by causing treatment delays, abandoned treatments, hospitalizations and patient deaths.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Cedars-Sinai to develop AI tool that predicts pancreatic cancer risk in Black patients

Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the disease.

December 06, 2024

Vol.50 No.45

Health Equity

Cedars-Sinai spearheads first national certification program for COE staff at cancer centers

The NCI Cancer Center Support Grant requires community outreach and engagement, but the design and implementation of COE programs, as well as staff training, are largely left to individual institutions.

November 22, 2024

Vol.50 No.44

By McKenzie Prillaman

In Brief

Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

Jupiter Bioventures, a biotechnology venture foundry that builds science-driven therapeutics companies, announced the closing of a $70 million initial financing.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence method to make launching cancer clinical trials easier and faster. The method uses patients’ pathology reports to automate the classification of patients by the severity of their cancers, potentially shortening the process of selecting candidates for clinical trials.

November 22, 2024

Vol.50 No.44

Indrin Chetty named vice chair of research, director of medical physics division in Department of Radiation Oncology at Cedars-Sinai

YOU MAY BE INTERESTED IN

UT Southwestern brings radiation oncology to $177M campus in Fort Worth Medical District

ASTRO survey finds prior authorization delays lead to serious harm for people with cancer

Cedars-Sinai to develop AI tool that predicts pancreatic cancer risk in Black patients

Cedars-Sinai spearheads first national certification program for COE staff at cancer centers

Two Neds—Ned David and Ned Sharpless—form Jupiter Bioventures and close $70M in initial financing

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

Renew today!

Subscriber content

Never miss an issue!

Login